A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-positive Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Contact: Study coordinator (Yanqiao Zhang)
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Weijian Guo)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction

Metastatic Gastric Adenocarcinoma · Metastatic Gastroesophageal Junction Adenocarcinoma · Peritoneal Carcinomatosis

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Metastatic Breast Cancer · Metastatic Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Cerritos, United States · Los Angeles, United States

IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of Resectable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

CLDN18.2 Positive · Primary Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Beijing, China

AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer

Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Harbin, China